Otolaryngology, ENT & Sinus News Provided by Dallas ENT

Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution - Corrected Proof

June 22, 2011, 12:00 pm by American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

Abstract: Background: T1 and T2 tonsillar squamous cell cancer with limited neck disease can be managed with single-modality radiation or surgery. Over 11 years, 17 patients underwent radical tonsillectomies; and 33 patients underwent radiation-based treatments for T1 and T2 and N0 to N2a tonsil cancer. Patients were intended to receive single-modality treatment based on presentation; however, some ultimately received adjuvant treatments.Methods: A retrospective chart review to compare overall survival (OS), disease-specific survival (DSS), and locoregional control (LRC) between the groups was used.Results: In surgical group, of 17 patients, 11 underwent surgery alone, 3 underwent surgery and radiation, and 3 underwent surgery with concurrent chemoradiation. Five-year OS for the surgical and radiation groups was 93% and 72%, respectively (no significance achieved). Five-year DSS rates (93% and 80%) and LRC (69% and 89%) similarly did not yield any significant difference.Conclusion: Surgery remains a viable option in the management of T1 and T2 tonsillar cancers with comparable LRC, OS, and DSS.

Read the full article


More from American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press

Healthcare disparities in revisits for complications after adult tonsillectomy
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: November 20, 2014, 12:00 pm
Determine if disparities exist for revisit complications after adult tonsillectomy.

Acute vocal fold dystonic reaction to Propofol: A case report
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: November 18, 2014, 12:00 pm
A 67-year old male underwent uneventful robotic-assisted thorascopic resection of a solitary pulmonary fibrous tumor. Immediately following extubation at the completion of the surgical procedure, the patient developed respiratory distress that did

Is partial laryngectomy safe forever?
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: November 18, 2014, 12:00 pm
Over past decades, function-preserving surgery has been oncologically effective for specific types of laryngeal cancer. Although safe short-term swallow function has been reported, swallow safety during long-term survival has received less attention.

Histone Deacetylase Inhibitor Sodium Butyrate Attenuates Gentamicin-Induced Hearing Loss
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: November 18, 2014, 12:00 pm
Although histone deacetylase (HDAC) inhibition has been shown to protect against gentamicin (GM)-induced hearing loss in vitro, its protective effect has not been proven in vivo. In the present study, the aim

Comprehensive Network Analysis of Genes Expressed in human Oropharyngeal Cancer
American Journal of Otolaryngology - Head and Neck Medicine and Surgery - Articles in Press: November 18, 2014, 12:00 pm
Oropharyngeal cancer (OPC) is the eighth most common cancer worldwide, however the genes involved in the development of OPC have been reported few. We constructed a co-expression network to extend knowledge of

 

NOTICE: The Dallas ENT web site "Otolaryngology ENT Industry News" has data and links presented by way of the above mentioned RSS news feeds. We offer this industry news for your convenience and education. Dallas ENT does not review the information provided in this section. Dallas ENT does not assume any endorsement or present these third-party feeds and links as Dallas ENT belief or in conjunction with Dallas ENT whatsoever. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by Dallas ENT. For more information, please see our disclaimer.